# The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).

Study · id `cardio:ct-nct04408430` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04408430](<https://clinicaltrials.gov/study/NCT04408430>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04408430

Browse, organ or system: Heart  
Browse, condition area: Heart failure; Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 210 participants.

## Technical summary

Registry record NCT04408430. Non-randomized; no masking; primary purpose treatment. Start 2021-03-08 (actual); primary completion 2026-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 210 participants (planned count; ClinicalTrials.gov record NCT04408430, source copy `cardio:ctgov-nct04408430-2026-01-13`, retrieved 2026-10-26)
- Started: 2021-03-08 (actual) (ClinicalTrials.gov record NCT04408430, source copy `cardio:ctgov-nct04408430-2026-01-13`, retrieved 2026-10-26)
- Primary completion: 2026-12 (anticipated) (ClinicalTrials.gov record NCT04408430, source copy `cardio:ctgov-nct04408430-2026-01-13`, retrieved 2026-10-26)
- Completion: 2030-12 (anticipated) (ClinicalTrials.gov record NCT04408430, source copy `cardio:ctgov-nct04408430-2026-01-13`, retrieved 2026-10-26)
- Countries: United States; Mexico (ClinicalTrials.gov record NCT04408430, source copy `cardio:ctgov-nct04408430-2026-01-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04408430-2026-01-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
- Acronym: MITRAL-II
- Condition: Mitral Annular Calcification
- Condition: Mitral Stenosis
- Condition: Mitral Regurgitation
- Condition: Mitral Valve Disease
- Intervention (Device): Transseptal ViMAC
- Lead sponsor: Mayra Guerrero
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Mitral regurgitation (`cardio:mitral-regurgitation`)
- Registry condition terms include this condition: Mitral stenosis (`cardio:mitral-stenosis`)

## Provenance

Content hash: e6ea7319c5b2cffe06ec97bf7932ee127947c4b5690bb46edc2d1f3b75cdced9
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
